Word

MYCURE

Status

Dead

Status Code

606

Status Date

Monday, October 26, 2020

Serial Number

86110838

Mark Type

4000

Filing Date

Tuesday, November 5, 2013

Published for Opposition

Tuesday, July 25, 2017

Abandoned Date

Monday, October 26, 2020

Trademark Owner History

MyCure, LLC - Owner At Publication

Classifications

1 Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for medical and scientific research purposes; Reagents for scientific or medical research use

5 Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting mutation in prion genes for medical purposes; Clinical diagnostic preparations for medical use; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of immunotherapy, and for identifying and characterizing immune dysfunction

41 Consulting services in the field of medical education, namely, providing information about education and training relating to the identification, diagnosis and treatment of medical and genetic conditions; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and genetics field; Education services, namely, providing training programs in the field of genetics; Conducting workshops and seminars in genetic testing and disease identification and treatment; Organization of seminars, working groups, research groups and conventions in the fields of medicine, genetics and scientific research; On-line journals, namely, blogs featuring commentary and information in the fields of DNA identification techniques, practices, and tools; Organization of conferences and symposia for the discussion, dissemination and exchange of scientific data and ideas on topics of interest to the scientific community; Providing educational demonstrations regarding biology, molecular biology, genetics, DNA sequencing and bioinformatics; Conducting educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics; Conducting classes, seminars and workshops in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course materials in connection therewith; Educational services, namely, conducting educational programs in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Organizing exhibitions for education in biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Providing courses of instruction in the fields of biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course material in connection therewith; Teaching in the fields of biology, molecular biology, genetics, genomics, DNA sequencing and bioinformatics and nature study

42 Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of genetics and human disease; Medical and scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for medical and scientific research purposes; DNA collection, testing and analysis services for medical and scientific research purposes; Genetic testing for diagnostic purposes; Genomic testing for diagnostic purposes; Medical and scientific research, development and consulting in the field of oncology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials; Diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; Identification of target molecules for cancer treatment; Proteogenomic profiling; DNA-sequencing for medical and scientific research purposes; Targeted pharmaceutical drug development services; Genotyping; Gene screening; Gene isolation and gene expression analysis for medical and scientific research purposes; Gene mapping; Gene analysis and biomarker discovery for medical and scientific research purposes

44 Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical and scientific research purposes; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling

MY CURE

Trademark Events

Oct 26, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Oct 26, 2020

Abandonment - No Use Statement Filed

Feb 19, 2020

Notice Of Approval Of Extension Request E-Mailed

Feb 18, 2020

Extension 5 Granted

Feb 13, 2020

Extension 5 Filed

Feb 18, 2020

Case Assigned To Intent To Use Paralegal

Feb 13, 2020

Teas Extension Received

Sep 14, 2019

Notice Of Approval Of Extension Request E-Mailed

Sep 12, 2019

Extension 4 Granted

Sep 12, 2019

Extension 4 Filed

Sep 12, 2019

Teas Extension Received

Feb 15, 2019

Notice Of Approval Of Extension Request E-Mailed

Feb 13, 2019

Extension 3 Granted

Feb 13, 2019

Extension 3 Filed

Feb 13, 2019

Teas Extension Received

Sep 12, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 10, 2018

Extension 2 Granted

Sep 10, 2018

Extension 2 Filed

Sep 10, 2018

Teas Extension Received

Aug 15, 2018

Teas Change Of Correspondence Received

Mar 15, 2018

Notice Of Approval Of Extension Request E-Mailed

Mar 13, 2018

Extension 1 Granted

Mar 13, 2018

Extension 1 Filed

Mar 13, 2018

Teas Extension Received

Sep 19, 2017

Noa E-Mailed - Sou Required From Applicant

Jul 25, 2017

Official Gazette Publication Confirmation E-Mailed

Jul 25, 2017

Published For Opposition

Jul 5, 2017

Notification Of Notice Of Publication E-Mailed

Jun 20, 2017

Law Office Publication Review Completed

Jun 15, 2017

Approved For Pub - Principal Register

Jun 1, 2017

Examiner's Amendment Entered

Jun 1, 2017

Notification Of Examiners Amendment E-Mailed

Jun 1, 2017

Examiners Amendment E-Mailed

Jun 1, 2017

Examiners Amendment -Written

May 5, 2017

Lie Checked Susp - To Atty For Action

May 4, 2017

Assigned To Lie

Oct 25, 2016

Report Completed Suspension Check Case Still Suspended

Apr 14, 2016

Report Completed Suspension Check Case Still Suspended

Oct 8, 2015

Report Completed Suspension Check Case Still Suspended

Oct 8, 2015

Assigned To Lie

Mar 30, 2015

Report Completed Suspension Check Case Still Suspended

Sep 9, 2014

Notification Of Letter Of Suspension E-Mailed

Sep 9, 2014

Letter Of Suspension E-Mailed

Sep 9, 2014

Suspension Letter Written

Aug 22, 2014

Teas/Email Correspondence Entered

Aug 21, 2014

Correspondence Received In Law Office

Aug 21, 2014

Teas Response To Office Action Received

Feb 27, 2014

Notification Of Non-Final Action E-Mailed

Feb 27, 2014

Non-Final Action E-Mailed

Feb 27, 2014

Non-Final Action Written

Feb 21, 2014

Assigned To Examiner

Nov 16, 2013

Notice Of Pseudo Mark E-Mailed

Nov 15, 2013

New Application Office Supplied Data Entered In Tram